Skip to main content
Caplight Logo









Otto

Otto

Private
Austin, TexasHealthcare & Life Scienceshttps://otto.vet/

Last Round

Series B

Aug 31, 2023

Total Funding Raised

$52.6M

Company Overview

Otto is a veterinary technology company that offers a software platform to enhance care delivery in veterinary clinics through remote healthcare solutions, automated client communications, and AI-powered workflow tools.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Workflow Automation, Medical AI, Patient Engagement, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Payment Processing Fee, Revenue Share

AI Layer

Application

Keywords

veterinary softwarepractice management systemPIMSveterinary AI scribevet techclinical documentationworkflow automationSOAP note generationveterinary SaaSclient communication platformveterinary payment processingAI-powered clinic toolswellness plan managementvet clinic automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Otto Comparables

Compare Otto with similar companies based on industry and business-model similarity.

Otto comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Digitail
87%
PetDesk
85%
Rhapsody
83%

Otto Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 31, 2023
Series AJun 12, 2020
SeedJan 7, 2020
SeedDec 1, 2019

Key People

Founding team and executive leadership

Steven Carter

Co Founder Chief Product Officer

Founding Team

Zeynep Young

CEO

Executive Team

Andy Michaelis

Chief Technology Officer

Executive Team

Lilly Liu

CFO

Executive Team

Otto Investors

Notable investors and investment history

Otto investors
InvestorRounds
Boehringer IngelheimSeries B
GAN VenturesSeed
GAN VenturesSeed
GAN VenturesSeries A
Atento CapitalSeries A
Urban Capital NetworkSeries A
Dundee Venture CapitalSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 13, 2025

    Launched Otto AI Recap, a standalone AI scribe tool.

  • Dec 1, 2019

    $2.3M round led by Dundee Venture Capital and Mercury Fund.

Otto Filings

Explore SEC and related filing metadata, where available.

Otto filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Otto's valuation, stock price, and market status.

Is Otto a public or private company?

Otto is a private company.

What is the current stock price of Otto?

Otto is a private company with no public stock price. No recent secondary market data is available.

How much is Otto worth (valuation)?

Valuation information for Otto is not publicly available.

Can I buy Otto stock?

Otto shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Otto's last funding round?

Otto's most recent funding round was Series B on August 31, 2023.

Who are the main investors in Otto?

Key investors in Otto include Dundee Venture Capital, Mercury Fund.

Will Otto IPO soon?

No public IPO plans have been announced for Otto.

How can I track Otto secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Otto's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAustin, Texas
Employee Range68
Year Founded2015
Last FundingAug 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?